Evidence, Controversies, and Practical Progress of Early Initiation of SGLT2 Inhibitors in Hospitalized Patients With Acute Heart Failure

{"Admission":[0],"for":[1,11,36,46,136,224],"acute":[2],"heart":[3,37],"failure":[4,38],"(AHF)":[5],"represents":[6],"a":[7,32,54,132,188],"critical":[8],"therapeutic":[9,34,104,134],"window":[10],"intervention.":[12],"Conventional":[13],"therapies":[14],"centered":[15],"on":[16,186],"maintaining":[17],"hemodynamic":[18,161],"balance":[19],"fail":[20],"to":[21,213],"improve":[22],"patients'":[23],"long-term":[24,236],"prognosis.":[25],"Sodium-glucose":[26],"cotransporter":[27],"2":[28],"inhibitors":[29],"(SGLT2is)":[30],"constitute":[31],"pivotal":[33],"agent":[35],"(HF),":[39],"and":[40,43,66,97,116,127,166,196,231,244,251],"the":[41,61,71,148,151,245],"timing":[42],"dosing":[44],"strategies":[45],"their":[47],"early":[48,72,85],"administration":[49],"after":[50,201],"hospitalization":[51],"have":[52],"become":[53],"major":[55,64],"research":[56,82,110,218],"focus.":[57],"This":[58],"review":[59],"summarizes":[60],"evidence":[62,223],"base,":[63],"controversies,":[65],"real-world":[67],"clinical":[68,91,95,145,181,209,240],"application":[69],"regarding":[70],"use":[73],"of":[74,87,150,160,164,238,247],"SGLT2is":[75,174],"in":[76,143],"patients":[77,177,214,230],"with":[78,178,215,233],"AHF.":[79,216],"Our":[80],"previous":[81],"demonstrated":[83],"that":[84,114],"initiation":[86,153,191],"SGLT2i":[88,204],"therapy":[89,205],"following":[90],"stabilization":[92],"significantly":[93],"improves":[94],"outcomes":[96],"reduces":[98],"HF":[99,137,179],"readmission,":[100],"representing":[101],"an":[102],"innovative":[103],"strategy.":[105],"Prior":[106],"work":[107],"from":[108],"our":[109],"group":[111],"also":[112],"indicated":[113],"kidney-tonifying":[115],"blood-activating":[117],"prescriptions":[118],"can":[119],"ameliorate":[120],"myocardial":[121,129],"energy":[122],"metabolism,":[123],"alleviate":[124],"inflammatory":[125],"responses,":[126],"mitigate":[128],"fibrosis,":[130],"identifying":[131],"promising":[133],"target":[135],"treatment.":[138],"Nevertheless,":[139],"several":[140],"debates":[141],"persist":[142],"routine":[144],"practice,":[146],"including":[147],"definition":[149],"\\"early\\"":[152],"window,":[154],"patient":[155,194],"selection":[156],"criteria":[157],"(particularly":[158],"assessment":[159],"stability),":[162],"risks":[163],"hypovolemia,":[165],"diabetic":[167],"ketoacidosis.":[168],"Recent":[169],"international":[170],"guidelines":[171],"recommend":[172],"initiating":[173],"promptly":[175],"once":[176],"achieve":[180],"stability.":[182],"Successful":[183],"implementation":[184],"relies":[185],"establishing":[187],"multidisciplinary":[189],"in-hospital":[190],"pathway,":[192],"enhancing":[193],"education,":[195],"optimizing":[197],"transitional":[198],"care":[199],"communication":[200],"hospital":[202],"discharge.":[203],"yields":[206],"substantial":[207],"net":[208],"benefits":[210],"when":[211],"administered":[212],"Future":[217],"priorities":[219],"should":[220],"include":[221],"generating":[222],"special":[225],"populations":[226],"such":[227],"as":[228],"elderly":[229],"those":[232],"multiple":[234],"comorbidities,":[235],"evaluation":[237],"hard":[239],"endpoints,":[241],"cost-effectiveness":[242],"analyses,":[243],"development":[246],"individualized":[248],"precision":[249],"diagnosis":[250],"treatment":[252],"strategies.":[253]}